|
[1]
|
Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
Frontiers in Genetics,
2022
DOI:10.3389/fgene.2022.820135
|
|
|
|
|
[2]
|
Unraveling the Role of Guanylate-Binding Proteins (GBPs) in Breast Cancer: A Comprehensive Literature Review and New Data on Prognosis in Breast Cancer Subtypes
Cancers,
2022
DOI:10.3390/cancers14112794
|
|
|
|
|
[3]
|
The role of interferons in ovarian cancer progression: Hinderer or promoter?
Frontiers in Immunology,
2022
DOI:10.3389/fimmu.2022.1087620
|
|
|
|
|
[4]
|
Guanylate‐binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients
Journal of Clinical Laboratory Analysis,
2021
DOI:10.1002/jcla.23610
|
|
|
|
|
[5]
|
Guanylate-binding proteins induce apoptosis of leukemia cells by regulating MCL-1 and BAK
Oncogenesis,
2021
DOI:10.1038/s41389-021-00341-y
|
|
|
|
|
[6]
|
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients
Leukemia & Lymphoma,
2021
DOI:10.1080/10428194.2021.1913147
|
|
|
|
|
[7]
|
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma
Cancers,
2021
DOI:10.3390/cancers13164043
|
|
|
|
|
[8]
|
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients
Leukemia & Lymphoma,
2021
DOI:10.1080/10428194.2021.1913147
|
|
|
|
|
[9]
|
Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
Frontiers in Oncology,
2020
DOI:10.3389/fonc.2019.01494
|
|
|
|
|
[10]
|
Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer
Frontiers in Immunology,
2020
DOI:10.3389/fimmu.2019.03139
|
|
|
|
|
[11]
|
Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells
Cancers,
2020
DOI:10.3390/cancers12020488
|
|
|
|
|
[12]
|
Guanylate‐binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients
Journal of Clinical Laboratory Analysis,
2020
DOI:10.1002/jcla.23610
|
|
|
|
|
[13]
|
Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease
The Journal of Experimental Medicine,
2019
DOI:10.1084/jem.20182031
|
|
|
|
|
[14]
|
Guanylate‐binding protein‐2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel‐resistant colorectal cancer cells by interfering Wnt signaling
Journal of Cellular Biochemistry,
2019
DOI:10.1002/jcb.29358
|
|
|
|
|
[15]
|
Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease
Journal of Experimental Medicine,
2019
DOI:10.1084/jem.20182031
|
|
|
|